Analysis reveals inflation adversely affects living standards and public health in low-income populations, indicating urgent policy interventions are needed.
Inflation—the sustained increase in the general price level of goods and services—presents a significant economic and social challenge with substantial impacts on living standards, financial stability, and public health. This paper explores the multifaceted impacts of inflation, with a particular focus on its disproportionate effects on low-income and fixed-income populations. Inflation directly impacts access to essential goods and services—such as food, housing, and healthcare—compelling households to make trade-offs that often result in adverse health outcomes. Malnutrition, limited access to medical care, and elevated rates of stress-related illnesses represent some of the most pronounced health consequences. In developing countries, such as Pakistan, inflation has intensified financial pressures on households, reducing their consumption of nutritious food and essential healthcare services. Among low-income populations, these compromises worsen existing health disparities, perpetuating a cycle in which poor health reduces economic productivity and deepens poverty. Escalating healthcare costs introduce an additional burden, rendering many individuals unable to afford treatment, medications, or preventive services. In addition, inflation exerts indirect effects on mental health, as financial instability contributes to increased levels of stress, anxiety, and depression, particularly among vulnerable populations. Households striving to manage constrained budgets often face difficult decisions, including prioritizing immediate expenses over long-term health investments. This paper also highlights inflation’s impact on savings, as it erodes the real value of savings, complicating efforts to secure financial stability and access to health-related services. Policymakers must address inflation’s dual economic and health effects through targeted interventions—such as subsidies for essential goods, improved access to healthcare, and initiatives aimed at price stabilization.
No takes yet. Share an insight, caveat, or question.
Akram et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: